Isolation of Circulating Tumor Cells Based on Microfluidic Technology

Item Number: 591
Industry: Biomedical
Category: Oncology
Development Stage: Early Stage
Organisation Type: University
Country: South Korea
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D

DESCRIPTION

Circulating Tumor Cells (CTCs) can be used as a marker for cancer diagnosis, prognosis prediction, and treatment evaluation.

92018016_26.jpg


Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it


SIGN IN